Molecular Diagnostic Market
Molecular Diagnostic Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Molecular Diagnostic Market Size and Growth
The molecular diagnostic market is experiencing significant growth, driven by advancements in technology and increasing demand for precise healthcare solutions. Valued at approximately $11 billion in 2022, it is projected to expand at a CAGR of over 10% through 2030, reflecting heightened focus on personalized medicine and rapid testing methodologies. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Abbott
◍ Gen-Probe
◍ Danaher
◍ Thermo Fisher
◍ Siemens
◍ Qiagen
◍ BD
◍ bioMérieux
◍ GE
The molecular diagnostic market is competitive, with companies like Abbott, Gen-Probe, Danaher, Thermo Fisher, Siemens, Qiagen, BD, bioMérieux, and GE driving growth through innovation, product development, and partnerships. Their contributions include advanced technologies and expanded testing capabilities, enhancing disease detection and management.
- Abbott: ~$12 billion (2022)
- Thermo Fisher: ~$40 billion (2022)
- Danaher: ~$31 billion (2022)
Request Sample Report
Market Segmentation
By Application
Prenatal
Infectious disease
Cancer
Others
Request Sample Report
By Product
PCR instrument
ISH instrument
Gene chip matching Equipment
Request Sample Report
